Next Generation Sequencing Assay for Blood Cancers

Researchers Develop Targeted Next Generation Sequencing Assay for Myeloid Neoplasms

via GIPHY

Researchers from South Korea said they have developed a next-generation sequencing (NGS) assay to detect somatic mutations, translocations, and germline mutations in a single assay for the purpose of supplementing or replacing conventional tests in patients with myeloid neoplasms.

Writing in a recent issue of PLoS One, the researchers said were able to discover a high frequency of germline mutations in cancer predisposition genes. Patients with these mutations exhibited different clinical characteristics, suggesting that germline predisposition has significant clinical implications.

Genotyping Market Overview

Genotyping Market to Undergo Very High CAGR Growth by 2024 | A report by Illumina, Thermo Fisher Scientific, Agilent Technologies, Bioline, Qiagen, Danaher, F. Hoffmann-La Roche and other

Production, consumption, revenue, gross margin, cost, gross, market share, CAGR, and genotyping market influencing factors are outlined in this report. This report includes all company profiles for top players and brands as well as a synopsis of market definition, classifications and trends in the market. The genotyping market’s drivers and limitations were derived from a well-known SWOT analysis method. Regional market segmentation included North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa’s historical and forecast mandates. We took up their company profiles in order to truly understand these key players and brands. The genotyping report provides a far-reaching analysis of the genotyping market by type, application, player, and region. The Global genotyping Market Report has published all business profiles of leading players and brands. This report focuses on genotyping global, regional and business volume and value.

READ MORE …

Canopy Biosciences aims to capitalize on Sequencing Error-Correction

Canopy Biosciences Aims to Improve Rare Variant Detection With Error-Correction Sequencing Service

NEW YORK (GenomeWeb) – After receiving an exclusive license from the Washington University in St. Louis for its error-correction sequencing technology, startup Canopy Biosciences now plans to develop the bioinformatic tool further to identify and monitor ultra-rare gene variants in patient blood samples.

With the new license, Canopy will build upon its gene expression analysis portfolio by offering a streamlined research-use-only service for next-generating sequencing applications.

READ MORE …

Targeting Brain Tumors with Single-Cell RNA-seq

Brain Tumors Through the Single-Cell RNA Sequencing Lens: Researcher Interview with Mario Suvà

Read Peggy Wang’s interview with Mario Suvà for the National Cancer Institute. Dr. Suvà is an assistant professor of pathology at Massachusetts General Hospital and Harvard Medical School, an Institute Member at the Broad Institute, and uses single-cell RNA sequencing as a discovery tool for understanding brain cancer. Lean more about his work and this powerful new approach to understanding this important disease…

READ MORE …

Genome sequencing has been getting cheaper, but library preps haven't--until now

IDT lowers genomic barriers with targeted sequencing system

“Itegrated DNA Technologies (IDT) has introduced its rhAmpSeq targeted sequencing system, providing researchers with highly accurate, cost-effective and easy-to-use amplicon sequencing on Illumina next-generation sequencing (NGS) platforms. The rhAmpSeq chemistry enables multiplexing at impressive levels with high on-target rates and uniform coverage, delivering accurate results and accelerating projects. The system has wide-ranging applications, including human disease research and sample tracking and analysis, CRISPR genome editing analysis and agricultural biotechnology.”

READ MORE …